AB

AbClon Inc.

Develops antibody therapeutics and CAR-T for oncology and provides CRO services.

174900 | KO

Overview

Corporate Details

ISIN(s):
KR7174900001
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로 285 에이스트윈타워 1차 1401호, 구로구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

AbClon Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel antibody-based therapeutics, primarily for oncology. The company's core technological assets include the CAR-T platform for personalized cancer immunotherapies, the NEST (Novel Epitope Screening Technology) platform for discovering antibodies against unique epitopes on disease proteins, and the AffiMab platform for the agile development of bispecific antibodies. These platforms are designed to address refractory diseases by creating treatments with novel therapeutic effects. In addition to its therapeutic pipeline, AbClon provides contract research organization (CRO) services, including antibody production and purification.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-27 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.3 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-11 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.5 KB
2025-07-14 00:00
Share Issue/Capital Change
전환주식의전환가액조정 (전환우선주)
Korean 11.3 KB
2025-05-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 79.7 KB
2025-05-21 00:00
M&A Activity
[기재정정]투자판단관련주요경영사항 (CART 세포치료제 `AT101` 기술이전 계약 체결)
Korean 18.3 KB
2025-05-20 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.3 KB
2025-05-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 6.1 KB
2025-05-19 00:00
Share Issue/Capital Change
전환주식의전환가액조정
Korean 12.0 KB
2025-05-15 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 895.6 KB
2025-05-09 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 42.1 KB
2025-05-09 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 45.1 KB
2025-04-28 00:00
Audit Report / Information
[기재정정]감사보고서제출
Korean 29.9 KB
2025-04-28 00:00
Audit Report / Information
[기재정정]사업보고서 (2023.12)
Korean 522.3 KB

Automate Your Workflow. Get a real-time feed of all AbClon Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbClon Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AbClon Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland
EEZY
Elicio Therapeutics, Inc. Logo
Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.
United States of America
ELTX
enCore Energy Corp. Logo
American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.
United States of America
EU
ENERGY FUELS INC Logo
A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.
United States of America
UUUU
ENIGMATIG LTD Logo
Global expansion and regulatory compliance consultancy for the financial services industry.
United States of America
EGG
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan
7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610
Enveric Biosciences, Inc. Logo
Develops novel neuroplastogen drugs for severe mental health and addiction disorders.
United States of America
ENVB
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050
Evaxion A/S Logo
Develops AI-powered, personalized vaccines for cancer and infectious diseases.
United States of America
EVAX

Talk to a Data Expert

Have a question? We'll get back to you promptly.